Literature DB >> 6407684

Compliance of patients and physicians: experience and lessons from tuberculosis-I.

W Fox.   

Abstract

Entities:  

Mesh:

Year:  1983        PMID: 6407684      PMCID: PMC1548153          DOI: 10.1136/bmj.287.6384.33

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  14 in total

Review 1.  Directly observed therapy (DOT) for tuberculosis: why, when, how and if?

Authors:  L P Ormerod
Journal:  Thorax       Date:  1999-08       Impact factor: 9.139

2.  What is the best dosage schedule for patients?

Authors:  W Fox
Journal:  J R Soc Med       Date:  1992-05       Impact factor: 5.344

3.  The management of tuberculous meningitis.

Authors:  M Humphries
Journal:  Thorax       Date:  1992-08       Impact factor: 9.139

Review 4.  Patient education and counselling for promoting adherence to treatment for tuberculosis.

Authors:  James Machoki M'imunya; Tamara Kredo; Jimmy Volmink
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

5.  South African health-care system at the crossroads.

Authors:  S Matseoane
Journal:  J Natl Med Assoc       Date:  1997-05       Impact factor: 1.798

6.  Treatment of pulmonary tuberculosis in patients notified in England and Wales in 1978-9: chemotherapy and hospital admission. Medical Research Council Tuberculosis and Chest Diseases Unit.

Authors: 
Journal:  Thorax       Date:  1985-02       Impact factor: 9.139

7.  Re-emergence of tuberculosis.

Authors:  W Fox; D A Mitchison
Journal:  BMJ       Date:  1993-02-20

Review 8.  Tuberculosis in the UK, 1994: current issues and future trends.

Authors:  L P Ormerod; R J Shaw; D M Mitchell
Journal:  Thorax       Date:  1994-11       Impact factor: 9.139

9.  Trends in tuberculosis.

Authors:  K M Citron
Journal:  Postgrad Med J       Date:  1984-03       Impact factor: 2.401

10.  Community participation in primary health care (PHC) programmes: lessons from tuberculosis treatment delivery in South Africa.

Authors:  Samson Kironde; Martha Kahirimbanyi
Journal:  Afr Health Sci       Date:  2002-04       Impact factor: 0.927

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.